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Cell sorting has been an important process in both clinical testing and medical 
diagnostics, and is used in many applications ranging from emergency trauma evaluation 
to cystic fibrosis checkups1-4. Currently, efficient blood cell sorting needs to be done in a 
laboratory setting with dedicated machinery, and the process is expensive2, 5, labor 
intensive6 and time consuming3. Multiple microfluidic solutions have been proposed to 
address these issues, including separation through hydrodynamics7, magnetism8, 9, and 
dielectrophoresis10, 11. Although these devices alleviate some of the problems surrounding 
laboratory blood sorting, the chips remain complex, costly, and lacks the specificity 
needed to be used directly in a clinical setting12, 13. 
The purpose of this study is to investigate the effectiveness of a new cell sorting 
method: pulse width modulated periodic backflush in a dead-end filtration system. Dead-
end filtration is a cheaper, simpler approach to cell sorting; particles are passed directly 
through a membrane filter which blocks larger particles while passing smaller ones.  
Dead-end filtration is easy to implement, and often has higher sorting 
efficiencies12. The problem of particle throughput reduction due to clogging is alleviated 
by a periodic backflush mechanism that maintains high sorting efficiency while retaining 
particle throughput. We examine the impact of superimposing periodic backflush in a 
large fluidic system and create a prototype to validate this effect in a microfluidic 
environment. We use a mixture of staph epidermidis and lung epithelial cells to validate 











 With many diverse applications ranging from evaluating the severity of traumatic 
injury to monitoring organ health, efficient cell isolation has become an important 
requirement for multiple areas in medical diagnostics and clinical experimentation1-4. In 
diagnostics, blood cell isolation may be performed for clinical evaluation of trauma 
patients. In clinical testing, the separation of cystic fibrosis patients’ lunge epithelial cells 
from infectious bacteria may be required for further investigation about the disease, 
leading to disease diagnostics. 
 Traditional cell sorting requires manual labor in multiple steps in a laboratory 
including centrifugation, sorting, and analysis2, 5.  However, this process is costly 2, 5, 
cumbersome6, and time consuming3, making it inconvenient or non-viable in many 
situations. Many different approaches have been taken to address these issues, taking 
advantage of distinguishable properties such as hydrodynamics7, magnetism8, 9, and 
dielectrophoresis10, 11. While miniaturization of these platforms also allows for quick 
filtration and smaller sample quantity, many of these devices remain complex and 
expensive, and often also lack the specificity to be used in clinical settings12, 13. 
 Current Filtration Methods  
 A method of quick and precise cell sorting has been sought after due to its 
applications in clinical and diagnostic settings2. Initial attempts to separate blood through 
filters were done in macrosystems, where microfilters were fabricated and tested outside 
of a microfluidics platform. One novel iteration was fabricating filter membranes out of 
Parylene-C, a biocompatible, rigid polymer that could be etched to have uniform 
micropores14. Two of these microfilters could be stacked to create a bilayer microfilter, 
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and separable filters were prototyped to gather circulating tumor cells (CTCs) in blood15. 
Various microfilters like Parylene-C were created from different materials such as silicon 
or silicon nitride, but these filters had complex manufacturing methods that were not 
scalable for use in rigorous clinical testing16. Similar micro-patterned membrane filters 
were made from photolithography to alleviate this issue.  
 As these microfilter pores were round, the cells that clog the pore membrane may 
deform or lyse due to the increased stress around the cell17. To lessen the impact of stress 
on the cells at the pore membrane, a ‘flexible micro spring array’ (FMSA) membrane was 
created from parylene. FMSA membranes have a comb like structure, which allows fluid 
and smaller cells to pass through the filter while a large cell is trapped in the filter13. 
These FMSA devices allow greater throughput, maintain the same levels of cell viability, 
but also have complexities regarding manufacturing and scaling. 
 In macrosystems, the filter is bonded to polydimethylsiloxane (PDMS) or 
clamped with pressure, with one inlet and one outlet fitted with tubing. A syringe is at the 
end of the inlet, and is able to push through the filter system to effectively separate the 
desired components of the blood. The transition from macrosystems to microfluidic 
devices came when additional components were needed to increase the sorting efficiency, 
throughput, filtering time, and longevity from previous devices. One major problem with 
macrosystems was they did not address membrane fouling, or the decrease in filter 
efficacy due to eventual pore clogging12, 18. As a result, a new filter had to be used or the 
filter had to be manually cleared – both undesirable, labor-consuming tasks.  
 To address the issue of clogging, the Chen lab initially integrated a cross-flow 
system with their microfilter19. Using Polyethylene (glycol) Diacrylate (PEGDA) 
microfilters fabricated by photolithography, the lab ‘sandwiched’ the filter to PDMS 
layers to create a three-layer chip that included a main channel as well as a cross flow 
channel to clear the membrane. While managing to get a high capture efficiency of CTCs, 
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the device had poor capture purity, as high amounts of blood cells accumulated on the 
filter.  
 By implementing multiple PDMS microfilters within one chip, the Zare group 
achieved higher capture specificity while isolating multiple components within one 
device12. The Zare lab also incorporated cross flow channels to their system, but added 
another layer to their microfluidic device for pneumatic valves. This automated the 
collection and membrane clearance process as the open channels could now be 
controlled. Through this system, a sorting efficiency of ~99.7% could be achieved to 
isolate red blood cells and platelets from leukocytes.  
 As seen in the Zare lab, microfluidic devices can have a variety of 
implementations which make it very desirable for cell sorting. Pneumatic valves will 
allow complex channels and more precise liquid handling within the chip. Sensors can be 
added to detect and regulate different variables such as temperature and pH, which can be 
useful when processing cells for long periods of time. Actuators can be used in lieu of 
syringes to control and divert liquid flow. For example, a piezoelectric actuator was used 
to oscillate the flow within a microfluidic chip to eliminate particle clogging within the 
device19.  
 However, a major drawback of current microfluidics is that the intricacy of the 
devices increases as additional features are added onto the system. Almost all the current 
blood sorting microfluidics chips require clean room facilities for fabrication, as they use 
photolithography to pattern their microfilters and channels. The addition of more layers 
such as the Zare chip also increase the difficulty in chip bonding and alignment. Aside 
from the increase in manufacturing labor, there is also an increase in cost – both for 
access to a clean room facility and the photomasks required to create a mold. This may be 
detrimental in the transition to having widely available chips used for sorting. 
Commercially available membranes such as polycarbonate were previously undesirable 
for blood sorting due to poor sorting efficiencies compared to uniform, microfabricated 
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filters. However, now that cross flow and backflush systems can be implemented to clear 
the fouling that occurs within polycarbonate membranes, they may be viable alternatives 
to reduce the costs of creating an effective sorting chip. Adding these polycarbonate 
membranes in parallel may also be the solution for the poor throughput the filters 
normally have due to their smaller pore density.  
Dead-End Filtration with Periodic Backflush 
 One promising method of blood cell sorting is dead end filtration, which is cost 
effective, easy to implement12, relatively quick, and user friendly14. The biggest 
drawback to dead-end filtration is membrane fouling, or the loss of filter efficiency due to 
pore clogging by incoming particles. Over time, the filter’s throughput will decay 
exponentially due to membrane fouling. This problem is further complicated by the 
mechanical sensitivity of cells: any localized pressure on the cell membrane can lead to 
unwanted deformation or cell lysis.  
 The Sulchek lab has proposed a new method of clearing the fouling layer in dead-
end filtration systems through a fluid control mechanism called pulse width modulated 
(PWM) periodic backflush. In PWM periodic backflush, the liquid that traverses a 
membrane filter periodically changes to flow in the opposing direction. While the time of 
forward flushing is still greater than the time of backflush for a fixed fluid velocity, the 
periodic change in direction allows the system to maintain high throughput levels along 
with high sorting efficiency.  
 While PWM periodic backflush has been performed with microbeads on a 
macrofluidic level, it has not been implemented with living biological components or on 
a microfluidic level. The objective of this thesis is to explore both the clinical 
applicability of this system through the separation of epithelial cells and lung bacteria, 




MATERIALS AND METHODS 
A549 Lung Epithelial Cell Culture 
 Lung epithelial cancer cells (A549 cell line) were cultured in media consisting of 
89% Roswell Park Memorial Institute (RPMI) base, 10% Fetal Bovine Serum (FBS), and 
1% Penicillin-Streptomycin (Pen-Strep). Cells were kept in a CO2 incubator at 37 
degrees Celsius, and passaged every four days when the cells reached approximately 75% 
confluency. To passage the cells, the RPMI media was aspirated from the flask, and PBS 
was added to wash the cells. The PBS was then aspirated, and trypsin was added to 
detach the cells. Whole media was added to the detached cells to neutralize the trypsin, 
and centrifuged at 200xG for five minutes. After centrifugation, the cell pellet was 
isolated and resuspended in new whole media. The cells were then seeded at a lower 
confluency and incubated.  
Staphylococcus epidermidis Bacteria 
 Staphylococcus epidermidis was cultivated in a conical tube with LB broth as an 
analog for S. Aureus, a common infectious agent in Cystic Fibrosis. When the staph 
colony reached high turbidity, the bacteria solution was inoculated and seeded on an agar 
plated petri dish. After twelve hours, a new grown colony was reinoculated into a new 
conical tube. To determine the colony forming units (CFU) per volume, 0.1 mL of new 
bacterial broth was added to three different conical tubes diluted by 1:100, 1:10,000, and 
1:1,000,000 respectively. The tubes were vortexed until the bacteria were uniformly 
distributed, and 0.01 mL of the fluid from the tubes were inoculated and evenly spread 
onto agar coated plates. The plates were incubated for 24 hours, and the individual 
formed colonies were counted from the plate that had distinct, individual colonies. The 
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original number of CFU per mL of solution derived by multiplying the CFU by the given 
dilution factor and averaged between plates. 
Spiking Cell Culture with Staph Epidermidis 
  A sterile, neutral buoyancy, suspension media consisting of PBS, tween, percoll, 
and EDTA was created. The A549 cells were detached using the same procedure above 
and centrifuged to isolate the cells. 10uL of the cell suspension were transferred to a 
hemocytometer to count the number of cells per volume. The calculate volume of staph 
broth was also centrifuged, and both pellets were diluted in the suspension media. After 
mixing both tubes until the solution was uniform, the staph and cells were combined in 
the suspension media in a ratio of 50:1 respectively. 
Macrofluidic Filtration with Periodic Backflush 
 Two filters – a Whatman Nuclepore Track-Etch Membrane and a Whatman 
Cyclopore Track Etched Membrane were used to separate the cell-bacteria mixture. The 
filter was encased in tight housing and connected to a customized syringe pump. This 
system was set up vertically, with the syringe pump on the bottom, driving fluid flow 
with negative pressure differentials, and a magnetic mixer on the top chamber such that 
settling was minimized but would happen in the direction of the filter. 
 Prior to introducing the mixture, the system was primed with the suspension 
media to remove any air bubbles from interacting with the filtration process. After 
priming, the cell-bacteria mixture was added to the top chamber of the system. The 
syringe pump was used to experimentally test two scenarios – dead-end filtration without 
oscillation and dead-end filtration with PWM periodic backflush. For the periodic 
backflush, the ratio of forward flush to backward flush volume used was 1.22 (Duty cycle 
of 55%). This ratio was previously determined with microbeads to be the most effective 
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in terms of sorting efficiency without sacrificing a significant amount of throughput time. 
After the samples were processed completely, the permeate and retentate were collected. 
Microfluidic Filtration with Periodic Backflush 
Evaluation of polycarbonate filters for sorting 
 
Polycarbonate (PC) has been used in previous research for blood component 
filtration18. While these track-etched filters suffer in capture efficiency due to pore fusion 
and scattering17, they are much more cost effective than microfabricated membranes 
which require photolithography. As APTES-functionalized polycarbonate also bonds 
with PDMS, the polycarbonate membrane can be ‘sandwiched’ in-between two PDMS 
layers to create an effective filter chamber. Moreover, the proposed polycarbonate chip 
design allows for easy filter scalability in series or in parallel, which allows for high 
throughput and specific particle separation. Polycarbonate filters were determined to be 
suitable for use and testing for the backflush mechanism in a microfluidics setting. 
Creation of a one-chamber, two-channel prototype  
  
An aluminum 6061 plate was milled to contain the mold negative of a channel 
and a chamber (Fig. 1A). PDMS and its curing agent were mixed, poured on the mold, 
vacuumed to remove bubbles, and cured at 60°C for two hours. The cured PDMS was cut 
and fluidic access holes were punched at the ends of the channels. The pieces were then 
taped to ensure no dust contacted the surface.  
Polycarbonate membrane functionalization 
 
To bond polycarbonate to PDMS, surface modification had to be done on both 
substrates to create silanol groups, which will irreversibly bond to each other on 
contact20. After oxygen plasma treatment, the polycarbonate membranes are submerged 
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in a 5% (3-Aminopropyl) triethoxysilane (APTES) solution at 80°C. The functionalized 
polycarbonate surface molecules react with APTES transferring the silicon-carbon-amine 
chain of the APTES molecule to the polycarbonate surface. When treated with oxygen 
plasma a second time, the –NH2 end will be replaced with an –OH group, which can now 
bond with functionalized PDMS to form siloxane groups keeping the two materials 
together.  
PDMS chambers made from the aluminum molds were used to test the bond 
strength of the PDMS-PC-PDMS chip. As the bonding process required the two silanol 
groups to be in direct contact, all cured PDMS was kept taped and sealed to prevent 
contamination. Additionally, the APTES solution was heated under a fume hood after 
plasma treatment as hazardous vapors were created from the heating process. The 
polycarbonate filters were plasma treated and submerged into the APTES solution. After 
treatment, the filters were dried and plasma treated a second time with one PDMS slab. 
These two pieces were bonded, and immediately plasma treated again with the second 
PDMS slab. The second PDMS slab was bonded to finish fabrication. The detailed 
APTES functionalization procedure can be found in Appendix A.   
After ensuring that the microfluidic device had proper bonding between the three 
layers, surgical tubing was inserted at each end. The devices were tested to ensure that 














Figure 1: Aluminum Mold and Microfluidic Chip. An aluminum 6061 plate was milled with 
the negative shape of the microfluidic chip (A). After pouring the PDMS and curing agent 
mixture, the mold was put under a vacuum to remove any air bubbles, and placed in an oven at 
60°C for two hours. Two PDMS pieces, combined with a polycarbonate membrane, were used to 
create one microfluidic chip (B). 
 
Creation of sorting system using microfluidic chips 
 To facilitate precise backflush motion in the microfluidic chips, a two-syringe 
actuating system was built (Fig 2). The actuating system is able to translate the stepper 
motor’s rotation to a linear motion, moving the actuating plate to push and pull the 
syringe plunger. The stepper motors are controlled by an Arduino Mega with the Adafruit 
Stepper Motor Driver v2, which is able to send move commands to two stepper motors 
simultaneously. The system is comprised of laser cut acrylic plates, and a tapped, milled 
spacer that moves the plates as the stepper motor runs. The system is compatible with 
Hamilton gastight high precision syringes which will be able to actuate fluids more 





















Figure 2: CAD Model and Prototype of a Two-syringe Actuating System Compatible  
with Microfluidic Chip. A two syringe actuating system was designed and manufactured such 
that efficient oscillation can be performed on the polycarbonate filter microfluidic chip. The chip 
can be inserted onto a slot on the bottom of the system, and can connect to the syringes with 




 Several methods were used to analyze the samples post-filtration. For the first 
three trials, the permeate and control fluids were taken and processed with flow 
cytometer BD Accuri to analyze the composition of the mixtures. The forward scatter 
detection was used to distinguish the size of the particles. For trial three, the Nuclopore 
permeate samples were diluted, plated, and incubated such that the bacterial CFU counts 
could be analyzed. The resulting histograms were used to examine if improvements were 





Macrofluidic System – Flow Cytometry Analysis 
Figure 3: Trial 1 - Forward Scatter Histograms for Filtration Modes of 50:1 Mixture of 
Staph Epidermidis to A549 Cells. Staph Epidermidis and A549 cells were sorted with 
Cyclopore and Nuclepore filters at α of 100 and 55. Counts of the stock solution indicate the cell-
bacteria ratio is around 19:1 instead of the calculated 50:1; this may indicate cell shearing or 
degradation. There is still a small improvement seen in filtration with periodic backflush, 
especially with Cyclopore filters. Furthermore, the Nuclepore filters exhibit a high enrichment 
factor (7.84) compared to that of the Cyclopore filters (1.25).  
Table 1: Trial 1– Flow Cytometry Counts for Filtration Modes of 50:1 Mixture of Staph 
Epidermidis to A549 Cells. The number of particles found per subset. The counts below are in 
the same arrangement as the figure above.  
Stock  Cyclopore  Nuclepore  
Subset 1 Subset 2 Subset 1 Subset 2 Subset 1 Subset 2  
900,485 52,841 941,253 9,584 653,010 7,720 
  950,072 7,720 971,554 1,465 
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Figure 4: Trial 2 - Forward Scatter Histograms for Filtration Modes of 50:1 Mixture of 
Staph Epidermidis to A549 Cells. Similar to the first trial, the flow cytometer counts do not 
reflect the calculated ratio of bacteria to cells.  
 
Table 2: Trial 2– Flow Cytometry Counts for Filtration Modes of 50:1 Mixture of Staph 
Epidermidis to A549 Cells. The number of particles found per subset. The counts below are in 
the same arrangement as the figure above.  
 
Stock  Cyclopore  Nuclepore  
Subset 1 Subset 2 Subset 1 Subset 2 Subset 1 Subset 2  
136,099 4,602 75,094 265 93,629 99 






Figure 5: Trial 3 - Forward Scatter Histograms for Filtration Modes of 50:1 Mixture of 
Staph Epidermidis to A549 Cells. Similar to the first and second trials, the flow cytometer 
counts do not reflect the calculated ratio of bacteria to cells.  
 
Table 3: Trial 3– Flow Cytometry Counts for Filtration Modes of 50:1 Mixture of Staph 
Epidermidis to A549 Cells. The number of particles found per subset. The counts below are in 
the same arrangement as the figure above.  
 
Stock  Cyclopore  Nuclepore  
Subset 1 Subset 2 Subset 1 Subset 2 Subset 1 Subset 2  
790,970 1,144 999,536 164 999,829 49 





Figure 6: Flow Cytometry Counts for Samples Containing Only A549 Samples. Flow 
cytometry counts for a suspension mixture including only A549 samples during trial 1 (left) and 
trial 3 (right). There is a wide distribution in the size of the particles seen in the sample.  
Macrofluidic System – Permeate Plating 
Figure 7: Trial 3 – CFU Counts Comparing α = 55 and α = 100 Filtration for Nuclepore 
filters. After filtration, the permeate sample was placed on a petri dish and grown. The α = 100 
sample (left) had a count that was approximately 2,000 CFU per plate, while the α = 55 sample 
(right) was too numerous to count. This result shows the periodic backflush increases the 
bacterial count in the permeate, and implies that the flow cytometry counts include A549 cell 




Macrofluidic System – Analysis of Initial Test Runs 
 Based on the initial test runs, the effect of periodic backflush on a mixture of 
Staphylococcus epidermidis and A549 cells is unclear. However, based on the disparity 
seen in the CFU counts and the flow cytometry data, not all particles in the low forward 
scatter range may be bacterial particles. The CFU counts show a clear increase when 
periodic backflush is applied, which aligns with the expected results based on previous 
microbead sorting analyses. This, along with the absence of A549 cell sized particles in 
the flow cytometry data, shows that cell shearing and disintegration may be occurring 
during filtration, causing smaller, unwanted particles in the permeate. This may also be 
the reason why the flow cytometry data of the sample with only A549 cells has high 
variance in the size range of the cells.   
 A few factors may be in play leading to cell disintegration during filtration. One 
possibility is that the processing time of the cells after they are detached is too long. As 
A549 cells are adherent cells, they are not in their natural state after trypsinization and 
transfer to suspension media. The cells were in suspension for over one hour prior to flow 
cytometry analysis for the first set of trials. Taking flow cytometry data for an A549 cell 
sample at various time points will show if suspension of A549 cells over long periods is 
detrimental.  
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 A second factor that needs to be analyzed is the effect of cell shearing during 
filtration. Cell shearing and lysing was an issue previously identified in porous 
membranes17, and may occur on both Cyclopore and Nuclopore membranes. In future 
experiments, the bacteria may need to be tagged with fluorescence or dye to differentiate 
the flow cytometry datum. If cell fragments are confirmed to be present, the syringe 
actuator may need to run at a slower RPM, or new filter types such as the FMSA may 
need to be considered.  
 Additionally, future experiments may need a more precise bacterial count when 
creating the cell-bacteria mixture. As plating for CFU counts only gives an estimate on 
the amount of bacteria present, experiments may have high variance from the 50:1 
bacteria-epithelia ratio. Flow cytometer readings may show high numbers of smaller 
particles because a higher bacteria-cell ratio was introduced in the suspension media. To 
eliminate this possibility, a spectrophotometer can be used in tandem with plating to 
determine bacterial counts based on the optical density of the bacterial suspension.  
Microfluidic System - Exploring Effects of Periodic Backflush 
With successful bonding of the three-layer microfluidic chip and creation of a 
dual-syringe actuation system, experimentation can begin to start testing the backflush 
mechanism on a microfluidic level. Two mold materials were tested for the 
manufacturing process – acrylic and aluminum. One observation during leak-testing of 
these devices was that higher actuation pressures will cause chip leakage at the insertion 
point of the surgical tubing. This can be prevented by adding uncured PDMS on that 
surface and allowing the PDMS to seal the chip around the tubing.  
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 Moving forward, the produced polycarbonate filter chips need to be tested for 
microbead entrapment and unwanted flow within the device. If the polycarbonate 
membrane is not fully bonded or bonded with folds, microparticles entering the device 
may become irreversibly clogged within the membrane. Flow tests need to be performed 
to observe if any major losses are present with the bonded membrane. These tests may 
also be helpful in further optimizing the dimensions of the device if flow and throughput 
data can be gathered during experimentation.  
 After these tests are completed, the chips can be connected to the high precision 
syringes. External stopcocks can be added to control the flow within the device and 
remove air bubbles within the system. With stopcock implementation, the device can be 
primed, and backflush can be performed with a 50/50 microbead solution ratio for two 
and seven micrometer diameters. The concentration of beads before and after the filter 
can be analyzed to determine the efficiency of blackflush in increasing the throughput of 
dead end filtration while maintaining high levels of sorting efficiency. After validating 





 While initial macrofluidic test runs have been inconclusive in validating the 
effects of periodic backflush on cell-bacteria sorting, several improvement considerations 
have been identified for future experimental runs. By analyzing the effect of A549 cells 
in suspension media, examining the effect of cell shear during filtration, and collecting 
experimental data with different sources to eliminate variance, future test runs will 
provide more accurate indications on how periodic backflush affects cell sorting.  
 On a microfluidic level, the polycarbonate filter membrane was successfully 
integrated onto PDMS, creating a leak-free chip. Furthermore, a dual-syringe actuating 
system was prototyped which will be able to interface with the chip to facilitate periodic 
backflush filtration. Testing can begin with microbeads to examine if the microfluidic 
chip is capable of filtering at a similar capacity to its macrofluidic counterpart.  
 After validation of the periodic backflush mechanism on biological organisms and 
on a microfluidic level, a sorting device that facilitates this filtration mode can be 
commercialized. Ranging from blood tests to cystic fibrosis diagnostics, these chips may 





Procedure for bonding PDMS to polycarbonate 
 
1. Clean 50 mL beaker with Alconox, use deionized water to rinse and dry with 
Kimwipes. 
2. Create a solution of 5% APTES in water (by volume) using a pipette or syringe. 
3. Use a hotplate to heat APTES solution to 80°C. 
4. Put polycarbonate membrane inside plasma cleaner with the shiny side facing up. 
The membranes may need to be on a petri dish as they may flip when the vacuum 
to the chamber is turned on. Set RF level to high and wait one minute.  
5. Remove membrane with cleaned tweezers and place in 80°C APTES solution. 
Soak membrane for 20 minutes.  
6. Use tweezers to take membrane out of solution. Let the membranes dry on 
Kimwipes for twenty minutes.  
7. Put first PDMS slab as well as dried polycarbonate membrane in the plasma 
cleaner. After turning on the vacuum, set RF to high and wait one minute.  
8. Remove the PDMS slab and membrane from plasma cleaner. Gently place the 
membrane on the desired location on the PDMS slab and poke with tweezers. The 
polycarbonate-PDMS bonding should be visible in a similar manner to PDMS-
PDMS bonding.  
9. Repeat steps 7 and 8 with the second slab of PDMS and the PDMS-polycarbonate 
slab. 
 
AFTER BONDING, APPLY SOME PRESSURE TO THE COMPLETED DEVICE AND PUT IN 
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